Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • Healthcare & Life Sciences
Language:
English

Healthcare & Life Sciences

blue and violet wire-shaped patterns against a blue background
Insight | Topic

Healthcare & Life Sciences Hub

Stay apprised on key market trends, risks, opportunities and legal issues through our dedicated resources hub.
Read More

Healthcare and life sciences companies face immense opportunity and disruption. The increasing innovation in new product breakthroughs; interplay between drugs, devices and tech; cost pressures; and demand for patient centricity have created a melting pot for agility and change.

Businesses turn to Baker McKenzie to enter new markets, maximize operational efficiencies, build a long-term pipeline of innovative products and demonstrate efficacy. We provide commercial legal advice to help anticipate and manage new risk and avoid disconnect between global strategy and the law enabling your company to provide better care to patients across the globe.

Visit InsightPlus for our latest legal updates covering Healthcare & Life Sciences developments across the globe

Insight | Legal Update
UK General Election Manifesto and Policy Tracker
A summary of the policies outlined in the Conservative and Labour manifestos and an indication of what the potential impact on businesses and individuals may be.
Insight | Handbook
Ukrainian Laws in Wartime
Our guide provides an overview of the key features of wartime legislation.
Insight | Thought Leadership
Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific
Healthcare and life sciences breakthroughs offer opportunities to meet patient needs and create value, but rising costs and market uncertainty also apply significant pressure to operations.
Insight | Legal Update
WHO Releases AI Ethics and Governance Guidance for Large Multimodal Models
The WHO guidance summarizes the broad applications of LMMs in the healthcare industry, including recommendations for governments, and for public health and medical purposes.
Insight | Thought Leadership
The Year Ahead: Global Disputes Forecast 2024 Report
Our seventh annual report provides detailed analysis of disputes trends to prepare your organization for 2024.
Insight | Legal Update
Supporting clients to seize Korea’s substantial opportunities
Our lawyers discuss the abundant opportunities that Korea presents and how the JV supports clients with their Korea inbound and outbound investments and business expansion. 
Insight | Handbook
Guide to IPOs for Biotech and Pharma Companies
Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.
Insight | Legal Update
How Has 2023 Panned Out for the Life Sciences Industry in Asia Pacific?
Ben McLaughlin and Andrew Martin discuss key trends and developments in 2023.
Insight | Podcast
Talking M&A
From navigating the complexities of carve-outs or tech transactions to cross-border trends, gain expert insights and uncover key topics in a complex transactional landscape.
Insight | Podcast
The Health Pod
The Health Pod, Baker McKenzie's industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies.
Insight | Handbook
Doing Business in Peru 2023
The topics covered in this guide range from the promotion of private investment and tax regimes, to the general framework of the most important sectors in Peru.
View All Insight
News | Deal Announcement
Baker McKenzie advises CureVac on restructuring collaboration with GSK into a new licensing agreement
The new licensing agreement will allow each company to prioritize investment and focus on their respective mRNA development activities.
News | Deal Announcement
Baker McKenzie advises Mitsubishi Tanabe Pharma on the sale of the European Argatroban business to Ethypharm
Baker McKenzie advised Mitsubishi Tanabe Pharma Corporation on the conclusion of an agreement with Ethypharm for the sale and transfer of the antithrombin drug Argatroban business in Europe.
News | Firm News
Baker McKenzie’s Global India Practice Committee welcomes three new members
Four committee members have also been named to India Business Law Journal’s “The International A-List” for 2024.
News | Press Coverage
What the future holds for Biotech IPOs
Capital Markets Partners Adam Farlow and Sheng Chen shared their insights with BioSpectrum Asia. 
News | Case Announcement
Baker McKenzie represented Genomma Lab Internacional in the divestiture of its stake in Marzam
Leading global law firm Baker McKenzie announced today that the New York office represented Genomma Lab Internacional ("Genomma") in connection with the divestment of its stake in Mexican ...
News | Firm News
Baker McKenzie Continues M&A and Private Equity Practice Growth with Addition of Tobias Knapp in New York
Tobias "Toby" Knapp is the latest partner to join the Firm's global transactional group.
News | Firm News
Baker McKenzie Bags Law Firm of the Year in Five Categories at The ALB SE Asia Law Awards 2024
The Firm and its member firms across Asia Pacific were also shortlisted as finalists in 13 other categories.
News | Awards
Baker McKenzie Partner Aarthi Belani Recognized Among Silicon Valley Business Journal's 2024 Women of Influence
Partner Aarthi Belani has been named to Silicon Valley Business Journal's prestigious 2024 Women of Influence list. 
News | Deal Announcement
Baker McKenzie advises Sino Biopharmaceutical on its partnership with Boehringer Ingelheim to bring innovative cancer therapies to China
The two companies will develop and commercialize a number of Boehringer's innovative oncology products.
News | Deal Announcement
Baker McKenzie advises Idorsia on entering into significant global research and development collaboration agreements
Under the agreements Viatris will receive exclusive worldwide development and commercialization rights for two Phase 3 assets.
News | Firm News
Healthcare and Life Sciences in Asia Pacific: 2024 sets to see rising investment and innovation
According to Baker McKenzie's new digital report “Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific.” 
View All News
Events | Upcoming Webinar
Global Healthcare & Life Sciences Webinar Series
Our Global Healthcare & Life Sciences Webinar Series aims to share legal industry insights and provide practical guidance in the context of today's evolving world.
Events | Upcoming Webinar
Asia Pacific Competition Spotlight
Our new series explores sector-specific competition law and business challenges faced by legal counsel and business leaders in Asia Pacific.
View All Events

Ranked in the Top 4 Law Firms in the World for Life Sciences, Chambers Global

Americas

  • Ranked in Healthcare: Pharmaceutical/Medical Products Regulatory, Chambers USA 2024 (District of Columbia)
  • Band 1 for Life Sciences, Chambers Latin America 2024 (Mexico)
  • Band 2 for Life Sciences and Healthcare, Chambers Latin America 2024 (Peru)
  • Tier 1 for Life Sciences and Healthcare, Legal 500 Latin America 2024 (Argentina)
  • Tier 1 for Life Sciences, Legal 500 Latin America 2024 (Mexico)
  • Tier 2 for Life Sciences, Legal 500 Latin America 2024 (Colombia)
  • Impact Deal of the Year - Poseida Therapeutics/Takeda, LMG Life Sciences Americas 2022 (US)
  • Impact Deal of the Year - Pfizer/Trillium Therapeutics, LMG Life Sciences Americas 2022 (Canada)
  • FDA Regulatory Firm to Watch, LMG Life Sciences Awards 2020 (US)
  • Licensing and Collaborations Recommended Firm, LMG Life Sciences 2021 and 2020 (US)

Europe, Middle East and Africa

  • Band 1 for Life Sciences, Chambers Europe 2024 (Hungary)
  • Band 2 for Life Sciences, Chambers Europe 2024 (Germany and Spain)
  • Listed for Healthcare & Life Sciences (Industry Focus and Regulatory), Legal 500 EMEA 2024 (Germany)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 EMEA 2024 (France, Italy, Spain)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 UK 2024 (London)
  • Law Firm of the Year for Health and Research, Top Legal Industry Awards (Italy)
  • Regulatory Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Türkiye Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Impact Deal - Vifor Pharma/Sanifit, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)

Asia Pacific

  • Band 1 for Life Sciences (Asia Pacific Region), Chambers Global 2014 to 2024 Chambers Asia Pacific 2014 to 2024
  • Band 2 for Life Sciences, Chambers Asia Pacific 2024 (Australia)
  • Band 2 for Life Sciences (International Firms), Chambers Greater China Region 2024 (China)
  • Tier 2 for Healthcare and Life Sciences (Foreign Firms), Legal 500 Asia Pacific 2023 (China)

Explore Healthcare & Life Sciences

Healthtech and Biotech M&A

The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

>> 16-minute listen

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS

A three minute video discussing how the pandemic triggered a significant rise in SPAC investments in the healthtech sector.


healthcare icons on blue backgrounc

Healthcare & Life Sciences Supply Chain Webinar Series 

Focuses on the trends, issues and opportunities along each stage of supply chain life cycle for healthcare and life sciences companies.

Flares of different colored light against a black background

Guide to IPOs for Biotech and Pharma Companies

Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.


Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance in the context of today's evolving world.

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 5 minutes

Hyper-Hybridity

Explores trends and opportunities in digital health from the perspective of three key players in the ecosystem: healthcare and life sciences organizations, technology companies and investors
Banner for Promoting Medical Products Handbook

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

How We Can Help

Key Contacts

*Trench Rossi Watanabe (Brazil) and Baker McKenzie have executed a strategic cooperation agreement to consult on foreign law.